The US Bankruptcy Court approved the first amended disclosure statement of Genocea Biosciences, Inc. on March 21, 2023. The debtor had filed its first amended disclosure statement in the Court on March 21, 2013. March 21, 2023 has been fixed as voting record date.

The deadline to vote on the plan and plan objection deadline is April 25, 2023. The confirmation hearing for the plan has been scheduled for May 10, 2023.